New synthetic method of bazedoxifene
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 南京正济医药销售有限公司
- Publication Date
- 2014-12-24
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
(1) Technical field
[0001] The invention belongs to the technical field of medicine synthesis, in particular, the invention relates to a synthesis method of bazedoxifene, a medicine for treating postmenopausal women's osteoporosis. (2) Technical background
[0002] Bazedoxifene, English name Bazedoxifene, is an indole derivative, its chemical name is 1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-2-(4 -hydroxyphenyl)-3-methyl-1H-indole-5-ol. Its chemical structural formula is as follows:
[0003]
[0004] Bazedoxifene, originally developed by Wyeth, is a third-generation selective estrogen receptor modulator. Launched in Italy and Spain in April 2009, the trade name is Conbriza, which is used to treat osteoporosis in postmenopausal women.
[0005] There are mainly two synthetic methods of bazedoxifene reported in the literature at present.
[0006] 1. EP0802183, JP1998036346, and US5998402 use p-hydroxybenzyl alcohol as the starting material to be replaced by ethyl bromoacetate,...